Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: A pilot study

被引：108

作者：

Hundley, JL

Yosipovitch, G ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA

[2] Wake Forest Univ, Sch Med, Ctr Neurosci, Winston Salem, NC 27157 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2004.01.045

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Nocturnal pruritus is a significant problem for patients with inflammatory skin diseases and many systemic diseases. The oral therapies currently available have a limited effect, We present an open, uncontrolled pilot study of 3 patients with inflammatory skin diseases and severe nocturnal pruritus Who underwent treatment with mirtazapine (Remeron), a noradrenergic and specific serotonergic antidepressant. Mirtazapine is a safe medication Without serious side effects and may be an effective alternative for the treatment of nocturnal pruritus.

引用

页码：889 / 891

页数：3

共 24 条

[1]

Anttila SAK, 2001, CNS DRUG REV, V7, P249

[2] Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: An objective life quality measure [J].